Medications
Opioid use linked to higher risk of C. difficile infection
New research from the University of Georgia suggests that opioid use could make patients more vulnerable to infections.
Dec 8, 2025
0
0
Therapeutics: News and Research on Therapeutics
MeSH tree: E02
Obstetrics & gynaecology
How to talk with your doctor about HRT now that the black box warning has been removed
Hot flashes and night sweats are miserable, as anybody going through menopause can tell you.
Dec 8, 2025
0
0
Obstetrics & gynaecology
AI tools help choose best embryos for IVF
Artificial intelligence tools can now help choose the most promising embryos for in vitro fertilization (IVF), although experts have warned of some ethical concerns.
Dec 8, 2025
0
0
Diseases, Conditions, Syndromes
Immunotherapy works for sepsis thanks to precision approach
Immunotherapy for sepsis is effective when doctors tailor the treatment precisely to the patient's immune system condition. While earlier research showed little benefit of immunotherapy in sepsis, a new study demonstrates ...
Dec 8, 2025
0
34
Medications
Fish oil supplement halves serious cardiovascular events in patients on dialysis, clinical trial finds
A daily fish oil supplement has been shown to significantly reduce serious cardiovascular events in people receiving dialysis for kidney failure. The findings come from a major international clinical trial co-led in Australia ...
Dec 8, 2025
0
95
Oncology & Cancer
Childhood cancer catalog opens door to pediatric immunotherapy
A unique facility in Melbourne containing hundreds of childhood cancer tissue samples has produced a first-of-its-kind catalog of pediatric cancers to help identify how the immune system can target each one.
Dec 8, 2025
0
0
Oncology & Cancer
Aza–ven combination outperforms standard care in AML patients eligible for intensive chemotherapy
In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen of azacitidine and venetoclax compared with conventional induction chemotherapy. The azacitidine–venetoclax ...
Dec 8, 2025
0
0
Oncology & Cancer
Measurable residual disease shows strong potential as an early indicator of survival in patients with AML
Sensitive tests designed to detect very small numbers of remaining leukemia cells after treatment, known as measurable residual disease (MRD), may provide an early and reliable indicator of long-term outcomes for patients ...
Dec 8, 2025
0
0
Oncology & Cancer
Trial shows chemotherapy and radiation are comparable as pre-transplant conditioning for patients with B-ALL
In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received chemotherapy-based conditioning ...
Dec 8, 2025
0
0
Health
Nordic people know how to beat the winter blues. Here's how to find light in the darkest months
The Nordic countries are no strangers to the long, dark winter.
Dec 7, 2025
0
0
